Showing results (391-400 of 895) with videos related to
Sort By:
Pageof 90
Clinical Endocrinology|June 10, 2005
Circulating cortisone levels are associated with biochemical markers of bone formation and lumbar spine BMD: the Hertfordshire Cohort StudyMark S Cooper, Holly E Syddall, Caroline H D Fall, et al.Joint Bone Spine|October 18, 2017
Statin use and knee osteoarthritis progression: Results from a post-hoc analysis of the SEKOIA trialFlorent Eymard, Camille Parsons, Mark H Edwards, et al.International Journal of Environmental Research and Public Health|November 4, 2020
The Effects of Different Smoking Patterns in Pregnancy on Perinatal Outcomes in the Southampton Women's SurveyMartin M O'Donnell, Janis Baird, Cyrus Cooper, et al.The British Journal of Nutrition|August 15, 2022
Evaluation and interpretation of latent class modelling strategies to characterise dietary trajectories across early life: a longitudinal study from the Southampton Women's SurveyKathryn V Dalrymple, Christina Vogel, Keith M Godfrey, et al.Aging Clinical and Experimental Research|July 3, 2023
Efficacy of osteoporosis pharmacological treatments in men: a systematic review and meta-analysisCharlotte Beaudart, Céline Demonceau, Shaun Sabico, et al.Calcified Tissue International|April 11, 2012
Risk of fracture with thiazolidinediones: disease or drugs?Marloes T Bazelier, Peter Vestergaard, Arlene M Gallagher, et al.Journal of Osteoporosis|October 21, 2011
Lack of association of bone morphogenetic protein 2 gene haplotypes with bone mineral density, bone loss, or risk of fractures in menSatya S Varanasi, Stephen P Tuck, Sarabjit S Mastana, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 19, 2004
Evidence of sustained skeletal benefits from impact-loading exercise in young females: a 3-year longitudinal studyJaana A Nurmi-Lawton, Adam D Baxter-Jones, Robert L Mirwald, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 25, 2022
The need to distinguish intervention thresholds and diagnostic thresholds in the management of osteoporosisJohn A Kanis, Eugene V McCloskey, Nicholas C Harvey, et al.Pharmacoepidemiology and Drug Safety|September 26, 2006
Use of beta-2 agonists and risk of hip/femur fracture: a population-based case-control studyFrank de Vries, Sander Pouwels, Madelon Bracke, et al.Pageof 90